請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84517
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳彥元(Yen-Yuan Chen) | |
dc.contributor.advisor | 陳彥元(Yen-Yuan Chen | chen.yenyuan@gmail.com | ), | |
dc.contributor.author | Ying-Na Hsiao | en |
dc.contributor.author | 蕭吟娜 | zh_TW |
dc.date.accessioned | 2023-03-19T22:14:09Z | - |
dc.date.copyright | 2022-10-17 | |
dc.date.issued | 2022 | |
dc.date.submitted | 2022-09-22 | |
dc.identifier.citation | 1. Kini V, Ho PM. Interventions to Improve Medication Adherence: A Review. JAMA. 2018;320(23):2461-2473. doi:10.1001/jama.2018.19271 2. Cheen MHH, Tan YZ, Oh LF, Wee HL, Thumboo J. Prevalence of and factors associated with primary medication non-adherence in chronic disease: A systematic review and meta-analysis. Int J Clin Pract. 2019;73(6):e13350. doi:10.1111/ijcp.13350 3. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035. doi:10.1161/CIRCULATIONAHA.108.768986 4. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12(3):239-245. doi:10.18553/jmcp.2006.12.3.239 5. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-1841. doi:10.1001/archinte.166.17.1836 6. Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication Adherence: Truth and Consequences. Am J Med Sci. 2016;351(4):387-399. doi:10.1016/j.amjms.2016.01.010 7. Piña IL, Di Palo KE, Brown MT, et al. Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association. Prog Cardiovasc Dis. 2021;64:111-120. doi:10.1016/j.pcad.2020.08.003 8. Yap AF, Thirumoorthy T, Kwan YH. Systematic review of the barriers affecting medication adherence in older adults. Geriatr Gerontol Int. 2016;16(10):1093-1101. doi:10.1111/ggi.12616 9. Jerant A, Chapman B, Duberstein P, Robbins J, Franks P. Personality and medication non-adherence among older adults enrolled in a six-year trial. Br J Health Psychol. 2011;16(Pt 1):151-169. doi:10.1348/135910710X524219 10. Okunrinboye HI, Otakpor AN, Ilesanmi OS. Depression and medication-adherence in patients with hypertension attending a tertiary health facility in South-West Nigeria. Pan Afr Med J. 2019;33:27. doi:10.11604/pamj.2019.33.27.12941 11. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365-1372. doi:10.1093/eurheartj/eht462 12. Holt E, Joyce C, Dornelles A, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2013;61(4):558-564. doi:10.1111/jgs.12171 13. Han E, Sohn HS, Lee JY, Jang S. Health Behaviors and Medication Adherence in Elderly Patients. Am J Health Promot. 2017;31(4):278-286. doi:10.4278/ajhp.150205- QUAN-709 14. Marcum ZA, Zheng Y, Perera S, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Social Adm Pharm. 2013;9(6):817-827. doi:10.1016/j.sapharm.2012.12.002 15. Tsai KT, Chen JH, Wen CJ, et al. Medication adherence among geriatric outpatients prescribed multiple medications. Am J Geriatr Pharmacother. 2012;10(1):61-68. doi:10.1016/j.amjopharm.2011.11.005 16. Cooper C, Carpenter I, Katona C, et al. The AdHOC Study of older adults’ adherence to medication in 11 countries. Am J Geriatr Psychiatry. 2005;13(12):1067- 1076. doi:10.1176/appi.ajgp.13.12.1067 17. Olesen C, Harbig P, Barat I, Damsgaard EM. Correlation between the use of ‘over- the-counter’ medicines and adherence in elderly patients on multiple medications. Int J Clin Pharm. 2014;36(1):92-97. doi:10.1007/s11096-013-9892-7 18. Gonzalez JS, Tanenbaum ML, Commissariat PV. Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. Am Psychol. 2016;71(7):539-551. doi:10.1037/a0040388 19. Molloy GJ, Gao C, Johnston DW, et al. Adherence to angiotensin-converting- enzyme inhibitors and illness beliefs in older heart failure patients. Eur J Heart Fail. 2009;11(7):715-720. doi:10.1093/eurjhf/hfp059 20. Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf. 2009;18(8):672-681. doi:10.1002/pds.1766 21. Miller TA. Health literacy and adherence to medical treatment in chronic and acute illness: A meta-analysis. Patient Educ Couns. 2016;99(7):1079-1086. doi:10.1016/j.pec.2016.01.020 22. Lindquist LA, Go L, Fleisher J, Jain N, Friesema E, Baker DW. Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge medications. J Gen Intern Med. 2012;27(2):173-178. doi:10.1007/s11606-011-1886-3 23. Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc (2003). 2008;48(1):58-63. doi:10.1331/JAPhA.2008.07040 24. Lau HS, Beuning KS, Postma-Lim E, Klein-Beernink L, de Boer A, Porsius AJ. Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis. Pharm World Sci. 1996;18(2):63-68. doi:10.1007/BF00579707 25. Cárdenas-Valladolid J, Martín-Madrazo C, Salinero-Fort MA, et al. Prevalence of adherence to treatment in homebound elderly people in primary health care: a descriptive, cross-sectional, multicentre study. Drugs Aging. 2010;27(8):641-651. doi:10.2165/11537320-000000000-00000 26. Kendrick R, Bayne JR. Compliance with prescribed medication by elderly patients. Can Med Assoc J. 1982;127(10):961-962. 27. Lam PW, Lum CM, Leung MF. Drug non-adherence and associated risk factors among Chinese geriatric patients in Hong Kong. Hong Kong Med J. 2007;13(4):284- 292. 28. Castaldi PJ, Rogers WH, Safran DG, Wilson IB. Inhaler costs and medication nonadherence among seniors with chronic pulmonary disease. Chest. 2010;138(3):614- 620. doi:10.1378/chest.09-3031 29. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101(3):270-276. doi:10.1016/s0002- 9343(96)00172-6 30. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497. doi:10.1056/NEJMra050100 31. Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047 32. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074-1090; discussion 1073. doi:10.1016/S0149-2918(99)80026-5 33. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150(7):1509-1510. 34. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565-574; discussion 575-577. doi:10.1002/pds.1230 35. van Onzenoort HAW, Verberk WJ, Kessels AGH, et al. Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild- to-moderate hypertension. Am J Hypertens. 2010;23(2):149-154. doi:10.1038/ajh.2009.207 36. Nieuwkerk PT, Nierman MC, Vissers MN, et al. Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk. Am J Cardiol. 2012;110(5):666-672. doi:10.1016/j.amjcard.2012.04.045 37. Stacy JN, Schwartz SM, Ershoff D, Shreve MS. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009;12(5):241-254. doi:10.1089/pop.2008.0046 38. Walker EA, Shmukler C, Ullman R, Blanco E, Scollan-Koliopoulus M, Cohen HW. Results of a successful telephonic intervention to improve diabetes control in urban adults: a randomized trial. Diabetes Care. 2011;34(1):2-7. doi:10.2337/dc10- 1005 39. Thom S, Poulter N, Field J, et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA. 2013;310(9):918-929. doi:10.1001/jama.2013.277064 40. Castellano JM, Sanz G, Peñalvo JL, et al. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol. 2014;64(20):2071- 2082. doi:10.1016/j.jacc.2014.08.021 41. Ho PM, Lambert-Kerzner A, Carey EP, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186-193. doi:10.1001/jamainternmed.2013.12944 42. Stewart K, George J, Mc Namara KP, et al. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther. 2014;39(5):527-534. doi:10.1111/jcpt.12185 43. Hedegaard U, Kjeldsen LJ, Pottegård A, et al. Improving Medication Adherence in Patients with Hypertension: A Randomized Trial. Am J Med. 2015;128(12):1351-1361. doi:10.1016/j.amjmed.2015.08.011 44. de Bruin M, Oberjé EJM, Viechtbauer W, et al. Effectiveness and cost- effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial. Lancet Infect Dis. 2017;17(6):595-604. doi:10.1016/S1473-3099(16)30534-5 45. Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational Interviewing Improves Medication Adherence: a Systematic Review and Meta-analysis. J Gen Intern Med. 2016;31(8):929-940. doi:10.1007/s11606-016-3685-3 46. Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Prev Med. 2017;99:269-276. doi:10.1016/j.ypmed.2017.03.008 47. Ruppar TM, Dunbar-Jacob JM, Mehr DR, Lewis L, Conn VS. Medication adherence interventions among hypertensive black adults: a systematic review and meta-analysis. J Hypertens. 2017;35(6):1145-1154. doi:10.1097/HJH.0000000000001260 48. Carman KL, Dardess P, Maurer M, et al. Patient and family engagement: a framework for understanding the elements and developing interventions and policies. Health Aff (Millwood). 2013;32(2):223-231. doi:10.1377/hlthaff.2012.1133 49. Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient- centered care. N Engl J Med. 2012;366(9):780-781. doi:10.1056/NEJMp1109283 50. Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: multistage consultation process. BMJ. 2017;359:j4891. doi:10.1136/bmj.j4891 51. Buhse S, Kuniss N, Liethmann K, Müller UA, Lehmann T, Mühlhauser I. Informed shared decision-making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial. BMJ Open. 2018;8(12):e024004. doi:10.1136/bmjopen-2018-024004 52. Kunneman M, Branda ME, Ridgeway JL, et al. Making sense of diabetes medication decisions: a mixed methods cluster randomized trial using a conversation aid intervention. Endocrine. 2022;75(2):377-391. doi:10.1007/s12020-021-02861-4 53. Milky G, Thomas J. Shared decision making, satisfaction with care and medication adherence among patients with diabetes. Patient Educ Couns. 2020;103(3):661-669. doi:10.1016/j.pec.2019.10.008 54. Schoenthaler A, Rosenthal DM, Butler M, Jacobowitz L. Medication Adherence Improvement Similar for Shared Decision-Making Preference or Longer Patient- Provider Relationship. J Am Board Fam Med. 2018;31(5):752-760. doi:10.3122/jabfm.2018.05.180009 55. Yamane SS, De Gagne JC, Riggs A, Kimberly GD, Holye M. Assessment of a patient-centered initiative to improve hypertension management for adults with comorbid type 2 diabetes at a free clinic in the rural south. Nurs Forum. 2020;55(3):348-355. doi:10.1111/nuf.12434 56. Chang TJ, Bridges JFP, Bynum M, et al. Association Between Patient-Clinician Relationships and Adherence to Antihypertensive Medications Among Black Adults: An Observational Study Design. J Am Heart Assoc. 2021;10(14):e019943. doi:10.1161/JAHA.120.019943 57. Ward J, Kalsi D, Barnett N, Fulford BK, Handa A. Shared decision making in chronic medication use: Scenarios depicting exemplary care. Res Social Adm Pharm. 2020;16(1):108-110. doi:10.1016/j.sapharm.2019.04.047 58. Tan JP, Cheng KKF, Siah RCJ. A systematic review and meta-analysis on the effectiveness of education on medication adherence for patients with hypertension, hyperlipidaemia and diabetes. J Adv Nurs. 2019;75(11):2478-2494. doi:10.1111/jan.14025 59. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811. doi:10.1097/00005650-200209000-00009 60. Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54-65. doi:10.3121/cmr.2013.1113 61. Brodney S, Fowler FJ, Stringfellow V, Valentine KD, Barry MJ. National Survey of Decision-Making for Antidepressants and Educational Level. J Am Board Fam Med. 2020;33(1):80-90. doi:10.3122/jabfm.2020.01.190120 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84517 | - |
dc.description.abstract | 背景介紹 服藥順從性指的是,病患是否按醫師處方規定次數服用藥物,以及他們是否持續 照醫師處方服用藥物,好的服藥順從性比起新型的治療方法更能增進病人的健 康。影響服藥順從性的因素有很多面項,病人、藥物、看診醫師及一些系統性因 素等皆會影響服藥順從性。增加服藥順從性的策略也有很多,舉凡病人教育、藥 物管理及認知行為療法等等策略。近年來醫病關係變化,醫師不再像過去是主要 的單一決策者,醫病共享決策此種以病人為中心的看診模式更逐漸被提倡,而認 知行為的介入方式也漸被納入探討其和服藥順從性的關聯性。由過去的文獻回顧 可以發現,醫病共享決策對於高血壓的病人可以增加其服藥順從性,但對於糖尿 病的病人卻沒有辦法增加其服藥順從性,且主動式及共享式的醫病決策關係比起 較為被動式的醫病決策關係更能增加病人的服藥順從性。然而過去的文獻較少提 到醫病共享決策對於高血脂病人其服藥順從性是否有影響。過去的研究也顯示, 對於高血脂症或其他慢性疾病的病人而言,高服藥順從性的病人比低服藥順從性 的病人增加了 26%健康狀況的改善。因此可以知道,好的服藥順從性對於高血脂 症的病人來說可以有較好的健康狀況,也因此增加高血脂症病人的服藥順從性是 至關重要的議題。因此,本研究針對高血脂病人去探討醫病共享決策是否會影響 其服藥順從性。 研究方法與材料 本研究的受試者來自於臺大醫院金山分院門診病人。我們收集 182 例於門診具備 高血脂診斷的病人,請病人於看診結束後填答問卷,請病人填寫自覺其看診時和 醫生之間的醫病關係為何種醫病共享決策關係,共分成五個層次的醫病共享決策 關係分別對應不同的醫病共享決策模式(主動式、被動式、共享式),排除一例於 醫病共享決策題目填錯答案者,排除 29 例於宗教信仰、婚姻狀態、醫療保險、 月收入、疾病嚴重度等未填答完整有缺漏者,最終可納入分析之個案為 152 人。年齡分佈從 27 歲到 94 歲,平均年齡 64.1 歲,女性 92 位,男性 60 位。服藥順 從性的部份則是用藥物持有率來計算,藥物持有率越高表示其服藥順從性越好。 本研究以簡單及多重迴歸分析來探討藥物持有率及醫病共享決策之關係,並探討 問卷中各個變項和藥物持有率之關聯性。 結論 本研究之結果顯示,對於高血脂的病人而言,醫病共享決策並無法增加病人的服藥順從性,對於高血脂的病人來說,影響其服藥順從性的因素為月收入差異和不同的門診醫師,月收入高的病人其服藥順從性相對較差,而不同門診醫師之間即便醫病共享決策的方式類似,仍存在不同的服藥順從性差異,故不同門診醫師對病人服藥順從性的影響仍需待後續研究加以深入探討。 | zh_TW |
dc.description.abstract | Introduction Medication adherence refers to whether patients take the medication as prescribed by the physician. Good medication adherence can improv the patients health more than new treatment methods. There are many factors that affect medication adherence. Patients , drugs, physicians, and some systemic factors can all affect medication adherence. There are also many strategies to increase medication adherence, such as patient education, medication management, and cognitive behavioral therapy. In recent years, the doctor-patient relationship has changed. Physicians are no longer the main decision-makers as in the past. The concept of shared decision making between doctors and patients is gradually being promoted, and this cognitive behavioral intervention had gradually been included to explore its relationship with medication adherence. From the literature review , it can be found that the policy of shared decision making can increase the medication adherence rate among patients with Hypertension, but it cannot increase the medication adherence rate among patients with Diabetes mellitus. Compared with passive shared decision making policy, active and shared decision making policy increased medication adherence rate . However, previous literatures seldom mentioned about whether the policy of shared decision making affects the medication adherence rate among patients with hyperlipidemia. Previous studies have also shown that for patients with hyperlipidemia or other chronic disease, patients with high medication adherence rate increased their health status by 26% compared with those with low medication adherence rate. Therefore, it can be known that good medication adherence can lead to better health status for patients with hyperlipidemia. It is important to increase the medication adherence rate among patients with hyperlipidemia. Therefore, our study aimed at examining the association between shared decision making policy and medication adherence among patients with hyperlipidemia. Material and Method The subjects of this study were enrolled from outpatient clinics from the Jinshan Branch of National Taiwan University Hospital. We collected 182 participants who were diagnosed with hyperlipidemia in the outpatient clinic. The patients were asked to fill in the basic questionnaires after visiting the outpatient clinic, and the patients were asked to fill in what they think about the doctor-patient relationship during this outpatient clinic. The relationship was divided into five levels according to the questionnaires. The decision making relationships correspond to three different decision making modes(active, passive and shared). One case was excluded due to wrong answer about the questionnaires of shared decision making, and 29 cases were excluded due to wrong answer or unanswered about the questions related to religion, marital status, medication insurance, monthly income, and disease severity. There were 152 cases that could be finally included in the analysis. The age of patients ranged from 27 to 94 years old, with an average age of 64.1 years, 92 females and 60 males. The medication adherence rate is calculated by the Medication Possession ratio(MPR). The higher the Medication Possession ratio(MPR) means the better the medication adherence rate. Our study use simple and multiple linear regression analysis to analyze the relationship between Medication Possession ratio(MPR) and shred decision making. Our study also analyze the relationship between each variable in the questionnaire and Medication Possession ratio(MPR). Conclusion The result of this study show that for patients with hyperlipidemia, the policy of shared decision making cannot increase the medication adherence rate. Factors that affect the medication adherence rate are differences in monthly income and different outpatient physicians. Patients with higher monthly income have poor medication adherence rate. Even if similar policy of shared decision making among different outpatients physicians, there are still differences in medication adherence rates. It still need further research about the influence of different outpatients physicians on medication adherence rate . | en |
dc.description.provenance | Made available in DSpace on 2023-03-19T22:14:09Z (GMT). No. of bitstreams: 1 U0001-2109202220565600.pdf: 1190106 bytes, checksum: 0b827e9676fd7432c1d043bc236f387a (MD5) Previous issue date: 2022 | en |
dc.description.tableofcontents | 誌謝........................................................................................... i 中文摘要.................................................................................... ii 英文摘要..................................................................................... iv 第一章 研究問題......................................................................................................................1 第二章 研究動機......................................................................................................................1 第三章 文獻回顧......................................................................................................................2 第一節 服藥順從性的定義............................................................................................2 第二節 服藥順從性的重要性........................................................................................2 第三節 影響服藥順從性之因子...................................................................................2 第四節 服藥順從性的測量方式....................................................................................6 第五節 增加服藥順從性的策略與介入......................................................................8 第六節 行為策略的介入方式.....................................................................................10 第七節 何謂醫病共享決策..........................................................................................11 第八節 服藥順從性與醫病共享決策.........................................................................11 第九節 研究假設...........................................................................................................13 第四章 研究方法與設定.......................................................................................................13 第一節 收案人口...........................................................................................................13 第二節 收案對象...........................................................................................................14 第三節 定義變項...........................................................................................................14 第四節 統計分析...........................................................................................................16 第五章 研究結果.................................................................................................................16 第一節 收案人口分佈...................................................................................................16 第二節 影響服藥順從性之因素.................................................................................17 第三節 醫病共享決策和服藥順從性.........................................................................18 第四節 多變項線性迴歸分析.....................................................................................18 第六章 結果討論....................................................................................................................19 第七章 研究限制...................................................................................................................21 第八章 結論...........................................................................................................................21 第九章 圖表.............................................................................................................................22 表一....................................................................................................................................22 表二....................................................................................................................................24 表三....................................................................................................................................26 表四....................................................................................................................................26 表五....................................................................................................................................27 表六....................................................................................................................................28 表七....................................................................................................................................28 表八....................................................................................................................................29 表九....................................................................................................................................30 表十....................................................................................................................................30 表十一..............................................................................................................................30 表十二..............................................................................................................................30 表十三..............................................................................................................................31 第十章 參考資料....................................................................................................................31 | |
dc.language.iso | zh-TW | |
dc.title | 針對診斷為高血脂的病人,醫病共享決策與服藥順從性之間的關係 | zh_TW |
dc.title | Examining the association between shared decision-making and medication adhesion | en |
dc.type | Thesis | |
dc.date.schoolyear | 110-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林彥克(Yen-Ko Lin),林文元(Wen-Yuan Lin) | |
dc.subject.keyword | 高血脂,醫病共享決策,服藥順從性, | zh_TW |
dc.subject.keyword | Hyperlipidemia,Shared decision making,medication adherence, | en |
dc.relation.page | 36 | |
dc.identifier.doi | 10.6342/NTU202203768 | |
dc.rights.note | 同意授權(限校園內公開) | |
dc.date.accepted | 2022-09-23 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 醫學教育暨生醫倫理研究所 | zh_TW |
dc.date.embargo-lift | 2022-10-17 | - |
顯示於系所單位: | 醫學教育暨生醫倫理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-2109202220565600.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 1.16 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。